First Aid Burn Relief
NDC 11822-7800
Product Information
First Aid Burn Relief is a OTC MONOGRAPH NOT FINAL-approved product labeled by Rite Aid. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 11822-7800 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 11822-7800?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- LIDOCAINE (UNII: 98PI200987)
- LIDOCAINE (UNII: 98PI200987) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ALOE VERA LEAF (UNII: ZY81Z83H0X)
- DIAZOLIDINYL UREA (UNII: H5RIZ3MPW4)
- DISODIUM COCOAMPHODIPROPIONATE (UNII: 6K8PRP397M)
- EDETATE DISODIUM (UNII: 7FLD91C86K)
- GLYCERIN (UNII: PDC6A3C0OX)
- METHYLPARABEN (UNII: A2I8C7HI9T)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- PROPYLPARABEN (UNII: Z8IX2SC1OH)
- ALCOHOL (UNII: 3K9958V90M)
- .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
- TROLAMINE (UNII: 9O3K93S3TK)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1442274 - lidocaine 0.5 % Topical Spray
- RxCUI: 1442274 - lidocaine 5 MG/ML Topical Spray
* Please review the full disclaimer at the bottom of this page.
Patient Education
Tolnaftate
Tolnaftate stops the growth of fungi that cause skin infections, including athlete's foot, jock itch, and ringworm. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
[Learn More]
* Please review the full disclaimer at the bottom of this page.